Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Don’t panic. This is a solid investment IMHO hold for gold. Long and strong.
$TOMDF #bullish This is a rapid test that takes between two and 10 minutes to obtain results, compared with the nasal swab test currently in widespread use that takes two to three days for results. #CoronavirusTesting https://t.co/OGG80xw5lR pic.twitter.com/xV7SCmVzEw
— Randylus (@randylus) March 20, 2020
$CORG #bullish Expansion: Cordia has been working on accelerating the planned opening of its location in West Hollywood. The company was also offered a location in the Koreatown section of Los Angeles. #UberEats #grubhub #doordash https://t.co/V21N4TtVYQ @cordiakitchens pic.twitter.com/GCeqnjwBkS
— Randylus (@randylus) March 20, 2020
TOMDF has entered into an exclusive distribution agreement for the US & Israel w/ Gibraltar Brothers & Associates, LLC, a U.S.-based subsidiary of Shanghai Liangrun Biomedicine Technology Co., for its proprietary colloidal gold immunochromatography test
$TOMDF https://t.co/1JhPbS5Mhy https://t.co/MmFa4LUylS pic.twitter.com/JDOqyUOPU2
— Randylus (@randylus) March 19, 2020
Boom!!
Yes please. Thanks.
Ignore that last link was the wrong video, sorry.
Peter Klamka
CEO, President
What video is that?
TOMDF Todos and Provista Diagnostics, Inc. have agreed to use Provista's lab in Alpharetta, Georgia to conduct the validation required to launch the test in the U.S. under CLIA.
Todos entered into an exclusive option to acquire Provista, and this transaction is expected to close in the second quarter of 2020. All COVID-19 testing inquiries should be directed via email to covidtesting@provistadx.com.
I’m holding this one through the acquisition and up listing to the nasdaq.
GLTA
$TOMDF Todos and Provista Diagnostics, Inc. have agreed to use Provista's lab in Alpharetta, Georgia to conduct the validation required to launch the test in the U.S. under CLIA. https://t.co/F4EG6Y43sj
— Randylus (@randylus) March 20, 2020
Respectfully disagree. China is on the leading edge of biotech. This is not a bad investment. If your looking for profits, this is a buy and hold.
How is a newly marketed healthcare company that’s into r&d, considered a pump & dump. I don’t get your logic at all. The price action is reflecting general market conditions. Please don’t state your opinions without factual information.
SPOM CaroGen is currently raising between $7 to $10 million. Hepatitis vaccine human trials next!
$SPOM CaroGen is currently raising between $7 to $10 million. https://t.co/BP8eVe9bh2 pic.twitter.com/oLIfTpg6gv
— Randylus (@randylus) March 15, 2020
Boom! CaroGen!
$SPOM CaroGen has secured more than $3 million from Connecticut Innovations ( https://t.co/PeKxXdq6Hf), followed by G. P. Healthcare ( https://t.co/KaghlwpDw7), Shandong Province, China; and from non-dilutive funding sources such as grants and awards. https://t.co/Hwm1JPSo5Z https://t.co/KFZ4KBlr8S
— Randylus (@randylus) March 15, 2020
Post #42985
Well not no. They have estimates in their PR. Depends on testing success in Korea and the FDA Emergency approval they say is pending.
The reality is no one can answer the questions. When will it be discovered or when will it go to market. Bets are taken on who you think has the best development platform and experience.
You want to flip? Good luck! You want to invest in the future? I pick SPOM! You?
SPOM CaroGen of GerPang Healthcare. #CoronaVirusUpdates Farmington biotech teams with Yale to pursue COVID-19 vaccine | Hartford Business Journal
$SPOM CaroGen of GerPang Healthcare. #CoronaVirusUpdates Farmington biotech teams with Yale to pursue COVID-19 vaccine | Hartford Business Journal https://t.co/465GeUVClu
— Randylus (@randylus) March 15, 2020
DECN #CoronavirusTesting
GenViro! TM is a brand new product that will allow you to screen for the Coronavirus (COVID-19)! Product only works with GenUltimate!® TBG Avantage! Meter. Not yet available for sale, still in production. Emergency application in process.
pharmatechsolutions.co/genviro.html
$DECN #CoronavirusTesting
— Randylus (@randylus) March 15, 2020
GenViro! TM is a brand new product that will allow you to screen for the Coronavirus (COVID-19)! Product only works with GenUltimate!® TBG Avantage! Meter. Not yet available for sale, still in production.https://t.co/VEcAWCDyJZ pic.twitter.com/ncPUzUcqLz
Your welcome.
Yeah dilution is almost finished if not already. Only 22,546,833 issued to settle old debt. Page 23 and 24 of the quarterly. Will never see anything below .08 in my opinion.
Flip all you want. That’s your choice. I don’t think you can slow this monster. Have fun while your at it.
?$DECN GenViro. Field testIng in Daegu, Korea, the location of our factory and the hospital based testing site, and where 1200+ people have already been overcome by Coronavirus. South Korea only second to a China in testing numbers. #COVID19 ?
?https://en.m.wikipedia.org/wiki/COVID-19_testing?
$DECN GenViro. Field testIng in Daegu, Korea, the location of our factory and the hospital based testing site, and where 1200+ people have already been overcome by Coronavirus. South Korea only second to a China in testing numbers. #COVID19 https://t.co/jz1KkKbYcU
— Randylus (@randylus) March 15, 2020
$SPOM Working with @CaroGen2 on a Hepatitis vaccine. #COROVID19 is especially dangerous for people with this virus.
$SPOM Working with @CaroGen2 on a Hepatitis vaccine. #COROVID19 is especially dangerous for people with this virus. https://t.co/mcMUz3hIMIhttps://t.co/ogKATgx5qo pic.twitter.com/leF9XRX6vR
— Randylus (@randylus) March 15, 2020
$SPOM Developing Novel immunotherapies for infectious diseases and cancer. CaroGen a subsidiary or Gerpang Healthcare.
$SPOM Developing Novel immunotherapies for infectious diseases and cancer. CaroGen a subsidiary or Gerpang Healthcare. https://t.co/nUluIyU1Ck (chrome will translate) pic.twitter.com/37CIMiN47A
— Randylus (@randylus) March 15, 2020
$SPOM #bullish #healthcare #CoronavirusPandemic https://t.co/XkfpAwEyzk pic.twitter.com/7syDVdnuVD
— Randylus (@randylus) March 13, 2020
Respect the $SPOM and it’ll respect you. Biggest reverse merger in the OTC in the past 5 years. #fusiontriangle
http://investingbulletin.com/2020/02/new-merger-utilizing-fusion-triangle-opens-the-door-to-possibly-biggest-merger-to-hit-us-otc-markets-in-last-5-years/
$DECN Keith Berman, CEO of DECN commented, "GenViro for the Coronavirus (covid19) began as an outgrowth of our GenUltimate TBG product line. What makes the testing for the Coronavirus possible, and the GenUltimate TBG special, is the company's Impedance measurement technology.
$DECN Keith Berman, CEO of DECN commented, "GenViro for the Coronavirus (covid19) began as an outgrowth of our GenUltimate TBG product line. What makes the testing for the Coronavirus possible, and the GenUltimate TBG special, is the company's Impedance measurement technology.
— Randylus (@randylus) March 13, 2020
There’s no fast track. It’s an FDA emergency waiver request for diagnostic product approval.
— Randylus (@randylus) March 12, 2020
Yeah don’t forget too add yourself as a negative. Do you have access to the market makers books? Can you prove what you are alleging?
Don’t care about your opinion. You have no facts.
It’ll come back. Not concerned. I still don’t see any proof of your opinions.
There are still no supporting facts in your posts. All guessing.
I feel sorry for you and your inability to properly access the value of a 500 million dollar reverse merger.
Meant to say that T-Trade was 16% of yesterday’s dollar volume.
The only facts in your comment are that your comment has no truth. It’s all false. Also, the T-Trade was a buy and 16% of yesterday’s volume. If it had been posted during market hours, the stock would have closed green instead of red yesterday. What are you even talking about?
$SPOM #bullish #fusiontriange
@meihuaxu #updates #gerpanghealthcare #healthcare #medicine
"Bullish Close" (T-Trade Buy in, After the Bell - 456,877 Shares) Dollar Volume $374,862
$SPOM #bullish #fusiontriange @meihuaxu #updates #gerpanghealthcare #healthcare #medicine "Bullish Close" (T-Trade Buy in, After the Bell - 456,877 Shares) Dollar Volume $374,862 pic.twitter.com/32vevOOyLY
— Randylus (@randylus) March 11, 2020
A look back in time> .148 cents 2/17 and .379 2/18 - This is hella cheep right now peeps. You should be getting all you can at these sale prices. IMHO you’ve seen the DD and when filings hit your in for the ride of your life.
A look back in time> .148 cents 2/17 and .379 2/18 - This is hella cheep right now peeps. You should be getting all you can at these sale prices. IMHO you’ve seen the DD and when filings hit your in for the ride of your life 👊🏻⭐️👊🏻⭐️ https://t.co/UDkSG8zhFJ
— Randylus (@randylus) March 8, 2020
Hopefully we go organic again and the company holds true to the promises of filings. Need to start with Florida reinstatement. This should not take more than 2 weeks. They are on notice.
Fair enough. We’ll rise above. I see some support and this could be a good play still.